AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30707238 — intervention group
Group type: COMPARATOR
Intervention: Straight suture anchor insertion technique
Number of subjects: 20
Study 30707238 — intervention group
Group type: EXPERIMENTAL
Intervention: Anchors that perforated the glenoid
Number of subjects: 20
Study 30707238 — intervention group
Group type: EXPERIMENTAL
Intervention: Anchors that did not perforate the glenoid
Number of subjects: 20
Study 28340098 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride-containing adhesive resin
Number of subjects: 34
Study 28340098 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoride-containing adhesive resin
Number of subjects: 34
Study 26092821 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking 5h/week for 4 months
Number of subjects: 201
Study 26092821 — intervention group
Group type: COMPARATOR
Intervention: Control group (ordinary activities)
Number of subjects: 201
Study 23869185 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil at infusion rate of 0.1 μg·kg(‐1)·min(‐1) (Group L)
Number of subjects: 37
Study 23869185 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at infusion rate of 0.5 μg·kg(‐1)·min(‐1) (Group H)
Number of subjects: 37
Study 21047149 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance treatment for opioid dependence
Number of subjects: 1015
Study 21047149 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 1015
Study 21047149 — intervention group
Group type: COMPARATOR
Intervention: Patients diagnosed with schizophrenia
Number of subjects: 1015
Study 21047149 — intervention group
Group type: COMPARATOR
Intervention: Patients diagnosed with depression
Number of subjects: 1015
Study 19701514 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical roughening with a diamond‐coated bur
Number of subjects: 216
Study 19701514 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching with citric acid
Number of subjects: 216
Study 19701514 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of EDTA C
Number of subjects: 216
Study 19701514 — intervention group
Group type: EXPERIMENTAL
Intervention: Luting with Panavia 2.0 F
Number of subjects: 216
Study 19701514 — intervention group
Group type: COMPARATOR
Intervention: Luting with Rely X Unicem or ParaCem
Number of subjects: 216
Study 19701514 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 216
Study 17296307 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 189
Study 17296307 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 189
Study 15022297 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy with carboplatin chemotherapy
Number of subjects: 204
Study 15022297 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy with carboplatin chemotherapy
Number of subjects: 204
Study 15022297 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy without carboplatin chemotherapy
Number of subjects: 204
Study 11750220 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR‐1/Lactobacillus fermentum RC‐14 (once and twice daily)
Number of subjects: 42
Study 11750220 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 42
Study 11750220 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR‐1/Lactobacillus fermentum RC‐14
Number of subjects: 42
Study 9504572 — intervention group
Group type: EXPERIMENTAL
Intervention: Common iliac venous pressure (CIVP)
Number of subjects: 20
Study 9504572 — intervention group
Group type: COMPARATOR
Intervention: Superior vena cava pressure (SVCP)
Number of subjects: 20
Study 8000301 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of beta-carotene (BC) daily for 3 months
Number of subjects: 0
Study 8000301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2725335 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate 0.5 mg daily
Number of subjects: 36
Study 2725335 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate 1.0 mg daily
Number of subjects: 36
Study 2725335 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate 2.5 mg daily
Number of subjects: 36
Study 2725335 — intervention group
Group type: COMPARATOR
Intervention: Control group (oestrogen therapy only)
Number of subjects: 36
Study 781439 — intervention group
Group type: EXPERIMENTAL
Intervention: 410 mg of prednisone plus vitamins in descending doses over 10 days
Number of subjects: 51
Study 781439 — intervention group
Group type: COMPARATOR
Intervention: Vitamins
Number of subjects: 51
Study 31647350 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic needle assisted hernia repair (LNAR)
Number of subjects: 32
Study 31647350 — intervention group
Group type: COMPARATOR
Intervention: Open herniotomy (OH)
Number of subjects: 32
Study 30200193 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Number of subjects: 0
Study 30200193 — intervention group
Group type: COMPARATOR
Intervention: American Cancer Society diet (ACS)
Number of subjects: 0
Study 26351263 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyber Friendly Schools program (CFS) implemented in Grades 8 and 9 (aged 13-14 years)
Number of subjects: 3000
Study 26351263 — intervention group
Group type: COMPARATOR
Intervention: Usual practice control group
Number of subjects: 3000
Study 24916707 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivy leaves dry extract
Number of subjects: 30
Study 24916707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 22306626 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue Management Group (FMG)
Number of subjects: 19
Study 22306626 — intervention group
Group type: COMPARATOR
Intervention: General Stroke Education (GSE)
Number of subjects: 19
Study 20105150 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 microg.kg(‐1) over 10 min)
Number of subjects: 40
Study 20105150 — intervention group
Group type: COMPARATOR
Intervention: Propofol target controlled infusion
Number of subjects: 40
Study 17481578 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute psychological stress (induced by a frustrating computer task)
Number of subjects: 59
Study 17481578 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no acute psychological stress)
Number of subjects: 59
Study 17481578 — intervention group
Group type: EXPERIMENTAL
Intervention: High chronic stress group (post hoc division based on chronic daily stress questionnaire)
Number of subjects: 59
Study 17481578 — intervention group
Group type: EXPERIMENTAL
Intervention: Low chronic stress group (post hoc division based on chronic daily stress questionnaire)
Number of subjects: 59
Study 17481578 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic stress (high vs low)
Number of subjects: 59
Study 15677573 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy
Number of subjects: 664
Study 12406377 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (self-etching-priming system)
Number of subjects: 36
Study 12406377 — intervention group
Group type: COMPARATOR
Intervention: Prime & Bond NT (one-bottle system)
Number of subjects: 36
Study 10487100 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI > 30 (obesity)
Number of subjects: 1940
Study 10487100 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger men and women with less than seven years of school education
Number of subjects: 1940
Study 8767528 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone, vincristine, doxorubicin, idarubicin, or mitoxantrone
Number of subjects: 89
Study 8767528 — intervention group
Group type: COMPARATOR
Intervention: MDR positivity
Number of subjects: 89
Study 2342818 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunization with inactivated influenza vaccine (Mississippi 1/85; dosage: 110 micrograms HA)
Number of subjects: 57
Study 2342818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 6114968 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed masturbation (DM)
Number of subjects: 30
Study 6114968 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic desensitization (SD)
Number of subjects: 30
Study 6114968 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 30
Study 31498862 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine injection (0.1 or 0.2 cc)
Number of subjects: 110
Study 31498862 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine AVF construction without papaverine injection)
Number of subjects: 110
Study 31498862 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine injection
Number of subjects: 110
Study 31498862 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study 27634557 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker treatment
Number of subjects: 2906
Study 27634557 — intervention group
Group type: COMPARATOR
Intervention: No beta-blocker treatment
Number of subjects: 2906
Study 25942487 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape-wine extract
Number of subjects: 60
Study 25942487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25942487 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape juice extract
Number of subjects: 60
Study 24944264 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone treatment
Number of subjects: 294
Study 24944264 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 294
Study 22612887 — intervention group
Group type: EXPERIMENTAL
Intervention: 155°F blankets
Number of subjects: 156
Study 22612887 — intervention group
Group type: COMPARATOR
Intervention: 110°F blankets
Number of subjects: 156
Study 19171333 — intervention group
Group type: EXPERIMENTAL
Intervention: prolonged GnRHa (depot leuprolide acetate 3.75 mg every 28 days for three doses)
Number of subjects: 36
Study 19171333 — intervention group
Group type: COMPARATOR
Intervention: integrin-positive controls (no GnRHa)
Number of subjects: 36
Study 19171333 — intervention group
Group type: COMPARATOR
Intervention: integrin-negative controls (no GnRHa)
Number of subjects: 36
Study 16716615 — intervention group
Group type: EXPERIMENTAL
Intervention: memantine (20-30 mg daily, n=10)
Number of subjects: 19
Study 16716615 — intervention group
Group type: COMPARATOR
Intervention: placebo (n=9)
Number of subjects: 19
Study 16181212 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT platelets (PLTs)
Number of subjects: 523
Study 16181212 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT plasma
Number of subjects: 523
Study 16181212 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT PLTs or PCT plasma
Number of subjects: 523
Study 11932365 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dilation for 30 seconds (group I)
Number of subjects: 74
Study 11932365 — intervention group
Group type: COMPARATOR
Intervention: Balloon dilation for 180 seconds (group II)
Number of subjects: 74
Study 9806659 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic intraepithelial neoplasia (PIN)
Number of subjects: 52
Study 9806659 — intervention group
Group type: COMPARATOR
Intervention: Prostate carcinoma
Number of subjects: 52
Study 9806659 — intervention group
Group type: EXPERIMENTAL
Intervention: PIN at D18S34 (18q12.2‐12.3)
Number of subjects: 52
Study 9806659 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple foci of PIN
Number of subjects: 52
Study 9806659 — intervention group
Group type: COMPARATOR
Intervention: Multiple foci of prostate carcinoma
Number of subjects: 52
Study 9806659 — intervention group
Group type: EXPERIMENTAL
Intervention: Allelic imbalance in matched PIN and prostate carcinoma foci
Number of subjects: 52
Study 7622644 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 187
Study 7622644 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole 10 mg
Number of subjects: 187
Study 7622644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 2385207 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intravenous infusion of 10 mg of Propionibacterium avidum KP-40
Number of subjects: 0
Study 2385207 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative re-infusion of Propionibacterium avidum KP-40
Number of subjects: 0
Study 6156361 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil in combination with propranolol at a dosage ratio of 1:8
Number of subjects: 0
Study 6156361 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil in combination with propranolol at dosage ratios of 1:2 and 1:4
Number of subjects: 0
Study 6156361 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 0
Study 6156361 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 31533934 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical fitness training
Number of subjects: 200
Study 31533934 — intervention group
Group type: COMPARATOR
Intervention: Relaxation sessions (control group)
Number of subjects: 200
Study 27927282 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% sodium hypochlorite (SH1)
Number of subjects: 50
Study 27927282 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% sodium hypochlorite (SH2)
Number of subjects: 50
Study 27927282 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% Ricinus communis (RC)
Number of subjects: 50
Study 27927282 — intervention group
Group type: COMPARATOR
Intervention: 0.85% saline (C)
Number of subjects: 50
Study 25882910 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose LPS (0.4 ng/kg body weight)
Number of subjects: 26
Study 25882910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 23682628 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective caesarean section at 38 weeks
Number of subjects: 1272
Study 23682628 — intervention group
Group type: COMPARATOR
Intervention: Elective caesarean section at 39 weeks
Number of subjects: 1272
Study 21535913 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass MATA MPL (300-2000 standardized units/injection)
Number of subjects: 1028
Study 21535913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study 19415820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 9624
Study 19415820 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 9624
Study 19243323 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane plus remifentanil
Number of subjects: 36
Study 19243323 — intervention group
Group type: COMPARATOR
Intervention: Propofol plus remifentanil
Number of subjects: 36
Study 15705732 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic exercise (IKE)
Number of subjects: 19
Study 15705732 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic exercise (ITE)
Number of subjects: 19
Study 15705732 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 19
Study 14727971 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 182
Study 14727971 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 182
Study 14727971 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous myocardial revascularization (PMR) plus medical therapy
Number of subjects: 182
Study 14727971 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 182
Study 14727971 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct myocardial revascularization (DMR)
Number of subjects: 182
Study 14727971 — intervention group
Group type: EXPERIMENTAL
Intervention: Different devices used for revascularization
Number of subjects: 182
Study 9475445 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention (HBI)
Number of subjects: 762
Study 9475445 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 762
Study 8553675 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II induced hypertension chemotherapy (IHC)
Number of subjects: 26
Study 8553675 — intervention group
Group type: COMPARATOR
Intervention: AFM regimen (adriamycin, 5‐fluorouracil, mitomycin) without IHC
Number of subjects: 26
Study 2508019 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide
Number of subjects: 0
Study 2508019 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 0
Study 105101 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole (150 mg daily for 3 days at the onset of symptoms)
Number of subjects: 30
Study 105101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12715685 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline (Adavin 60 mg/d)
Number of subjects: 25
Study 12715685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 30541065 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50-100 mg/d
Number of subjects: 289
Study 30541065 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil 1,400-2,800 mg/d
Number of subjects: 289
Study 30541065 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Losartan and Fish oil
Number of subjects: 289
Study 30541065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 29624542 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot epidural block with 0.25% bupivacaine plus 4 mg of morphine (10 mL) combined with general anesthesia.
Number of subjects: 22
Study 29624542 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone with desflurane, cisatracurium, and any systemic analgesia.
Number of subjects: 22
Study 29624542 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (B and G)
Number of subjects: 22
Study 27388863 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated error experiences
Number of subjects: 0
Study 27388863 — intervention group
Group type: COMPARATOR
Intervention: Standard error education (movies)
Number of subjects: 0
Study 27388863 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (simulated error experiences and movies)
Number of subjects: 0
Study 24184028 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigated radiofrequency ablation
Number of subjects: 150
Study 24184028 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox-Maze lesion set
Number of subjects: 150
Study 24184028 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 150
Study 22774869 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliotherapy (self-help book)
Number of subjects: 45
Study 22774869 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 45
Study 20493481 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesiologist-administered sedation (AAS) using propofol-remifentanil (PR)
Number of subjects: 50
Study 20493481 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled sedation (PCS) using propofol-remifentanil (PR)
Number of subjects: 50
Study 17609490 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate (6.3 g per day containing 30 mg of polyphenols)
Number of subjects: 44
Study 17609490 — intervention group
Group type: COMPARATOR
Intervention: White chocolate (matching polyphenol‐free)
Number of subjects: 44
Study 16186518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis-based medicine (CBM)
Number of subjects: 66
Study 16186518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 12076905 — intervention group
Group type: EXPERIMENTAL
Intervention: CT angiography using multidetector CT (MDCT)
Number of subjects: 42
Study 10102459 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical prediction index for DVT
Number of subjects: 271
Study 7598064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet (1.47 g protein.kg body cell mass‐1.d‐1)
Number of subjects: 12
Study 7598064 — intervention group
Group type: COMPARATOR
Intervention: Adequate-protein diet (2.94 g protein.kg body cell mass‐1.d‐1)
Number of subjects: 12
Study 2358927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ender nails
Number of subjects: 149
Study 2358927 — intervention group
Group type: COMPARATOR
Intervention: Sliding nail plate
Number of subjects: 149
Study 689746 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic decontamination with neomycin, polymyxin, bacitracin, and nystatin (Group A)
Number of subjects: 82
Study 689746 — intervention group
Group type: COMPARATOR
Intervention: No decontamination, isolated (Group B)
Number of subjects: 82
Study 689746 — intervention group
Group type: COMPARATOR
Intervention: No decontamination, treated on the ward (Group C)
Number of subjects: 82
Study 31469017 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic debridement plus Shenghong wet dressing
Number of subjects: 60
Study 31469017 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic debridement plus recombinant human fibroblast growth factor (FGF) gel
Number of subjects: 60
Study 29496253 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction radiochemotherapy followed by consolidation chemotherapy (arm A)
Number of subjects: 125
Study 29496253 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy followed by consolidation concurrent radiochemotherapy (arm B)
Number of subjects: 125
Study 26902765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 0.5 g meropenem
Number of subjects: 6
Study 26902765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal administration of 0.5 g meropenem
Number of subjects: 6
Study 24961446 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video on VTE (5 min duration)
Number of subjects: 0
Study 24961446 — intervention group
Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 0
Study 23082222 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer use for >1 h/day
Number of subjects: 2579
Study 23082222 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased computer use by more than 30 min between 2001 and 2007
Number of subjects: 2579
Study 23082222 — intervention group
Group type: COMPARATOR
Intervention: TV viewing
Number of subjects: 2579
Study 20338954 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal analgesia (bupivacaine 7.5 mg)
Number of subjects: 64